Hikma
Hikma continues strong momentum across the Group and upgrades guidance for 2023
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutica...
- 1 month ago
Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa
London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical compa...
- 2 months ago
Hikma and Rakuten Medical sign exclusive licensing agreement for AlluminoxTM platform cancer treatment for the Middle East and North Africa
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical comp...
- 4 months ago
Hikma delivers strong H1 performance and raises Generics guidance Growth in all three businesses and across all geographies
Hikma Pharmaceuticals PLC and its subsidiaries (‘Hikma’ or ‘Group’), the multinational ...
- 4 months ago
Good momentum across all businesses and updated Generics guidance
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutica...
- 7 months ago
Riad Mishlawi named Chief Executive Officer of Hikma Pharmaceuticals PLC
Amman,Jordan — Hikma Pharmaceuticals PLC (Hikma, Group), announces that Riad Mishlawi, President o...
- 8 months ago
Hikma delivers a resilient underlying performance in 2022
Amman, Jordan — Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmace...
- 9 months ago
Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical comp...
- 11 months ago
Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region
London, England — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, an...
- 1 year ago
Hikma and Adalvo Sign Exclusive Licensing Agreement to Commercialise Allergic Rhinitis Medication across MENA Markets
Amman, Jordan — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, annou...
- 1 year ago
Hikma’s diversified business delivers resilient H1 performance
London, United Kingdom — Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational...
- 1 year ago
Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical compa...
- 1 year ago
Siggi Olafsson to step down as Chief Executive
London, United Kingdom - Hikma Pharmaceuticals PLC (Hikma) today announces that Siggi Olafsson has r...
- 2 years ago
